SNAP

BIG 2-12

Share This Post

Schedules of Nab-Paclitaxel: evaluation of different schedules of nab-paclitaxel for metastatic breast cancer

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Contenu de va-et-vient
Contenu de va-et-vient

This trial is coordinated and sponsored by the International Breast Cancer Study Group (IBCSG) under the umbrella of the Breast International Group.

Pharmaceutical partner: Celgene

Contenu de va-et-vient
Contenu de va-et-vient
Contenu de va-et-vient

Funding: Celgene grant

More To Explore

TRANS-BIG

TRANS-BIG TRANSBIG was an EU-funded consortium coordinated by the Breast International Group to promote collaboration in translational breast cancer research. Share this trial What TRANSBIG

Read More

DECRESCENDO

DECRESCENDO BIG 19-02 De-Escalation of adjuvant ChemotheRapy in HER2-positive, EStrogen reCEptor-negative, Node-negative early breast cancer patients who achieved pathological complete response after neoadjuvant chemotherapy and Dual HER2 blOckade Share

Read More